As the winter season approaches, France faces a new surge in COVID-19 infections, driven by a marked increase in viral circulation detected across wastewater networks and emergency departments, according to Actu.
Public health authorities report that transmission levels are climbing across multiple regions, though hospital admissions and severe disease metrics remain lower than those observed during previous autumn waves. The current epidemiological dynamic primarily affects adult populations, registering significant variations at the departmental level.
According to data published by Santé publique France, the national viral indicator derived from wastewater monitoring showed an increase from approximately 2,498 in mid-October to 3,509 during early November, representing a rise of roughly 40% over a three-week span. This environmental surveillance serves as an early warning system before clinical consultations surge.
During the week of November 9 to November 15, the proportion of deaths officially certified with COVID-19 as a contributing cause reached 1.80%, compared with 0.98% during the same period in the previous year, according to Parole de mamans. Despite these rising markers, health officials note that overall pressure on the healthcare system remains limited.

The acceleration of respiratory infections has triggered distinct geographical disparities across French departments. For the week of November 9, Lozère recorded the highest proportion of emergency room visits for suspected COVID-19, with 1,978 visits per 100,000 emergency admissions, according to actu.fr. This figure was followed by the Alpes-de-Haute-Provence at 1,324, Cantal at 1,242, Manche at 1,162, and Allier at 1,092.
Other regions experienced sharp percentage increases in emergency department suspicion rates over a single week. Epidemiologists caution that these dramatic percentage leaps often occur when starting baseline numbers are exceptionally low.
When evaluated on a regional scale, emergency department metrics highlight distinct clusters.

Baseline Immunity Reduces Severe Pulmonary Involvement
Baseline Immunity Protects Against Severity: Extensive population immunity from prior infections and vaccinations has shifted the clinical presentation of the virus closer to that of an upper respiratory tract infection or mild influenza, reducing severe pulmonary involvement.
Wastewater as an Early Warning: Viral concentration tracking in sewage treatment plants provides an advanced indicator of community transmission weeks before it translates into a heavy burden on doctors’ offices or hospitals.
Targeted Protection for Vulnerable Groups: Health agencies continue to emphasize autumn booster vaccinations for individuals aged 65 and older, as well as those managing chronic underlying pathologies.
| Region / Department | Key Metric | Reported Value (November 2026) |
|---|---|---|
| National Wastewater Indicator (SUM’eau) | Viral concentration index (Week 45) | 3,509 (up from 2,498) |
| Lozère | Suspected COVID-19 emergency visits per 100,000 | 1,978 |
| Corsica | Suspected COVID-19 emergency visits per 100,000 | 544 |
| Provence-Alpes-Côte d’Azur | Suspected COVID-19 emergency visits per 100,000 | 521 |
| Mortality Proportion | Percentage of total deaths mentioning COVID-19 | 1.80% (vs. 0.98% in 2025) |
Clinical experts attribute the controlled severity of the current wave to the persistent dominance of Omicron-lineage variants alongside broad population immunity.
This sentiment is echoed by specialists observing clinical manifestations in hospital settings. “This variant attacks the lungs less, it manifests more through upper respiratory infections, that is to say a cold or angina, so it is less severe,” Anne-Claude Crémieux, professor of infectious diseases at Saint-Louis Hospital in Paris, told ICI.
High-Risk Groups Should Consult Doctors Promptly
Individuals over the age of 65 and those with immunocompromising conditions or chronic respiratory and cardiovascular illnesses should consult a healthcare provider promptly upon developing symptoms.

Early medical evaluation is crucial for determining eligibility for antiviral therapeutics, which demonstrate optimal efficacy when administered during the initial stages of infection. Patients experiencing acute respiratory distress, persistent chest pain, or sudden confusion must seek emergency medical intervention immediately. Authorities advise wearing a well-fitting mask in crowded indoor spaces or when interacting with medically fragile individuals if symptoms appear.
Public health agencies continue to urge high-risk individuals to complete their seasonal vaccination regimens for both COVID-19 and influenza without delay, reinforcing personal and community defense mechanisms as winter progresses.
Santé publique France was created on 1 May 2016 under the Health System Modernization Law, merging three existing bodies: the Institut de veille sanitaire, the Institut national de prévention et d’éducation pour la santé, and the Établissement de préparation et de réponse aux urgences sanitaires.
The agency operates 15 regional intervention units and is governed by a 32-member board of directors that includes state representatives, health professionals, association representatives, local elected officials, and parliamentarians. Its first Contract of Objectives and Performance, covering 2018 to 2022, set six strategic goals spanning epidemiological surveillance, crisis preparedness, and prevention programs such as the “Tobacco-Free Month” campaign.
References
- Santé publique France. Weekly epidemiological bulletins on acute respiratory infections and wastewater surveillance (SUM’eau). Published November 2026.
- actu.fr. Regional reporting on COVID-19 emergency department admissions and departmental circulation data. Published November 21, 2026.
- Parole de mamans. Regional analysis of emergency department strain and vaccination recommendations. Published November 2026.
- 24matins. Epidemiological wave analysis and expert commentary on population immunity. Published November 2026.
- Doctissimo. Wastewater surveillance compilation and clinical impact assessments. Published November 2026.
Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.